Mauna Kea Technologies SAS (ALMKT) - Total Liabilities

Latest as of June 2025: €42.08 Million EUR ≈ $49.20 Million USD

Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has total liabilities worth €42.08 Million EUR (≈ $49.20 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Mauna Kea Technologies SAS - Total Liabilities Trend (2008–2024)

This chart illustrates how Mauna Kea Technologies SAS's total liabilities have evolved over time, based on quarterly financial data. See ALMKT working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Mauna Kea Technologies SAS Competitors by Total Liabilities

The table below lists competitors of Mauna Kea Technologies SAS ranked by their total liabilities.

Company Country Total Liabilities
Ntaw Holdings Ltd
AU:NTD
Australia AU$240.37 Million
Daechang Steel Co Ltd
KQ:140520
Korea ₩135.24 Billion
Aligos Therapeutics Inc
NASDAQ:ALGS
USA $32.77 Million
Cayman Tung Ling Co Ltd
TWO:2924
Taiwan NT$485.00 Million
Hotel Fitra International Tbk PT
JK:FITT
Indonesia Rp25.46 Billion
Seni Jaya Corporation Bhd
KLSE:9431
Malaysia RM73.50 Million
Bumi Benowo Sukses Sejahtera Pt
JK:BBSS
Indonesia Rp3.97 Billion
Progressive Planet Solutions Inc
V:PLAN
Canada CA$11.35 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Mauna Kea Technologies SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Mauna Kea Technologies SAS.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.23 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.02 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 3.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mauna Kea Technologies SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mauna Kea Technologies SAS (2008–2024)

The table below shows the annual total liabilities of Mauna Kea Technologies SAS from 2008 to 2024.

Year Total Liabilities Change
2024-12-31 €40.63 Million
≈ $47.51 Million
+1.04%
2023-12-31 €40.21 Million
≈ $47.01 Million
+1.25%
2022-12-31 €39.72 Million
≈ $46.43 Million
+13.21%
2021-12-31 €35.08 Million
≈ $41.02 Million
+7.34%
2020-12-31 €32.69 Million
≈ $38.21 Million
+39.88%
2019-12-31 €23.37 Million
≈ $27.32 Million
+98.32%
2018-12-31 €11.78 Million
≈ $13.78 Million
+7.09%
2017-12-31 €11.00 Million
≈ $12.86 Million
+24.79%
2016-12-31 €8.82 Million
≈ $10.31 Million
+4.81%
2015-12-31 €8.41 Million
≈ $9.83 Million
-10.40%
2014-12-31 €9.39 Million
≈ $10.98 Million
+0.03%
2013-12-31 €9.38 Million
≈ $10.97 Million
+5.50%
2012-12-31 €8.90 Million
≈ $10.40 Million
+1.95%
2011-12-31 €8.73 Million
≈ $10.20 Million
+71.94%
2010-12-31 €5.07 Million
≈ $5.93 Million
+25.77%
2009-12-31 €4.04 Million
≈ $4.72 Million
-15.20%
2008-12-31 €4.76 Million
≈ $5.56 Million
--

About Mauna Kea Technologies SAS

PA:ALMKT France Medical Devices
Market Cap
$34.50 Million
€29.51 Million EUR
Market Cap Rank
#23983 Global
#383 in France
Share Price
€0.15
Change (1 day)
-1.54%
52-Week Range
€0.07 - €0.22
All Time High
€5.37
About

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more